GLADIATOR: A global approach for elucidating disease modules

Genome Medicine

Volumn 9, Issue 1, 2017, Pages

  Silberberg, Yael ^a   Kupiec, Martin ^a   Sharan, Roded ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Disease gene prediction; Disease modules; Disease pathways; Graphs and networks; Hyperinsulinism; Protein protein interaction network

Indexed keywords

APOLIPOPROTEIN B; LIPOPROTEIN;

ALGORITHM; AMINO ACID SEQUENCE; ANALYTIC METHOD; ARTICLE; DISEASE ASSOCIATION; GENE CLUSTER; GENE ONTOLOGY; GENOME-WIDE ASSOCIATION STUDY; GLOBAL APPROACH FOR DISEASE ASSOCIATED MODULE RECONSTRUCTION; HIGH THROUGHPUT SCREENING; HUMAN; HYPERINSULINISM; LIPOPROTEIN METABOLISM; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENICITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; SYMPTOMATOLOGY; BIOLOGY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MOLECULAR GENETICS; PROCEDURES;

ALGORITHMS; COMPUTATIONAL BIOLOGY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERINSULINISM; METABOLIC NETWORKS AND PATHWAYS; MOLECULAR SEQUENCE ANNOTATION; PROTEIN INTERACTION MAPS;

EID: 85019766311     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/s13073-017-0435-z     Document Type: Article

References (54)

1. Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A. OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 2015;43:D789-798.
2. Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H, et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 2014;42:D1001-1006.
3. Schlicker A, Lengauer T, Albrecht M. Improving disease gene prioritization using the semantic similarity of Gene Ontology terms. Bioinforma Oxf Engl. 2010;26:i561-567.
4. Yousef A, Moghadam CN. SFM: a novel sequence-based fusion method for disease genes identification and prioritization. J Theor Biol. 2015;383:12-9.
5. Freudenberg J, Propping P. A similarity-based method for genome-wide prediction of disease-relevant human genes. Bioinforma Oxf Engl. 2002;18 Suppl 2:S110-115.
6. Chen L, Liu R, Liu Z-P, Li M, Aihara K. Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers. Sci Rep. 2012;2:342.
7. Liu X, Wang Y, Ji H, Aihara K, Chen L. Personalized characterization of diseases using sample-specific networks. Nucleic Acids Res. 2016;44:e164.
8. Navlakha S, Kingsford C. The power of protein interaction networks for associating genes with diseases. Bioinformatics. 2010;26:1057-63.
9. Vanunu O, Magger O, Ruppin E, Shlomi T, Sharan R. Associating genes and protein complexes with disease via network propagation. PLoS Comput Biol. 2010;6:e1000641.
10. Lage K, Karlberg EO, Størling ZM, Ólason PÍ, Pedersen AG, Rigina O, et al. A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat Biotechnol. 2007;25:309-16.
11. Köhler S, Bauer S, Horn D, Robinson PN. Walking the interactome for prioritization of candidate disease genes. Am J Hum Genet. 2008;82:949-58.
12. Xu J, Li Y. Discovering disease-genes by topological features in human protein-protein interaction network. Bioinformatics. 2006;22:2800-5.
13. Mazza A, Klockmeier K, Wanker E, Sharan R. An integer programming framework for inferring disease complexes from network data. Bioinformatics. 2016;32:i271-277.
14. Menche J, Sharma A, Kitsak M, Ghiassian SD, Vidal M, Loscalzo J, et al. Uncovering disease-disease relationships through the incomplete interactome. Science. 2015;347:1257601.
15. Ghiassian SD, Menche J, Barabási A-L. A DIseAse MOdule Detection (DIAMOnD) algorithm derived from a systematic analysis of connectivity patterns of disease proteins in the human interactome. PLoS Comput Biol. 2015;11:e1004120.
16. Leiserson MDM, Vandin F, Wu H-T, Dobson JR, Eldridge JV, Thomas JL, et al. Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes. Nat Genet. 2015;47:106-14.
17. Xu R, Li L, Wang Q. Towards building a disease-phenotype knowledge base: extracting disease-manifestation relationship from literature. Bioinforma Oxf Engl. 2013;29:2186-94.
18. Zhou X, Menche J, Barabási A-L, Sharma A. Human symptoms-disease network. Nat Commun. 2014;5:4212.
19. Köhler S, Doelken SC, Mungall CJ, Bauer S, Firth HV, Bailleul-Forestier I, et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Res. 2014;42:D966-974.
20. Rath A, Olry A, Dhombres F, Brandt MM, Urbero B, Ayme S. Representation of rare diseases in health information systems: the Orphanet approach to serve a wide range of end users. Hum Mutat. 2012;33:803-8.
21. Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M, Rajan D, et al. DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am J Hum Genet. 2009;84:524-33.
22. Phenopolis: an open platform for harmonization and analysis of sequencing and phenotype data. bioRxiv. 2016. http://biorxiv.org/content/early/2016/10/31/084582. Accessed 18 Dec 2016.
23. Gene Ontology Consortium. Gene Ontology Consortium: going forward. Nucleic Acids Res. 2015;43:D1049-1056.
24. Wu X, Jiang R, Zhang MQ, Li S. Network-based global inference of human disease genes. Mol Syst Biol. 2008;4:189.
25. Li Y, Patra JC. Genome-wide inferring gene-phenotype relationship by walking on the heterogeneous network. Bioinforma Oxf Engl. 2010;26:1219-24.
26. Piñero J, Queralt-Rosinach N, Bravo À, Deu-Pons J, Bauer-Mehren A, Baron M, et al. DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes. Database J Biol Databases Curation. 2015;2015:bav028.
27. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci. 2005;102:15545-50.
28. Fabregat A, Sidiropoulos K, Garapati P, Gillespie M, Hausmann K, Haw R, et al. The Reactome pathway Knowledgebase. Nucleic Acids Res. 2016;44:D481-487.
29. Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28:27-30.
30. Ovaska K, Laakso M, Hautaniemi S. Fast Gene Ontology based clustering for microarray experiments. BioData Min. 2008;1:11.
31. Resnik P. Semantic similarity in a taxonomy: an information-based measure and its application to problems of ambiguity in natural language. ArXiv11055444 Cs. 2011. http://arxiv.org/abs/1105.5444. Accessed 18 Dec 2016.
32. Matys V. TRANSFAC: transcriptional regulation, from patterns to profiles. 2003. https://www.ncbi.nlm.nih.gov/pubmed/12520026. Accessed 18 Dec 2016.
33. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell. 2005;122:957-68.
34. The implications of human metabolic network topology for disease comorbidity. 2008. http://www.pnas.org/content/105/29/9880. Accessed 18 Dec 2016.
35. Ruepp A, Waegele B, Lechner M, Brauner B, Dunger-Kaltenbach I, Fobo G, et al. CORUM: the comprehensive resource of mammalian protein complexes-2009. Nucleic Acids Res. 2010;38:D497-501.
36. Hornbeck PV, Kornhauser JM, Tkachev S, Zhang B, Skrzypek E, Murray B, et al. PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res. 2012;40:D261-270.
37. Vinayagam A, Stelzl U, Foulle R, Plassmann S, Zenkner M, Timm J, et al. A directed protein interaction network for investigating intracellular signal transduction. Sci Signal. 2011;4:rs8.
38. Chatr-Aryamontri A, Oughtred R, Boucher L, Rust J, Chang C, Kolas NK, et al. The BioGRID interaction database: 2017 update. Nucleic Acids Res. 2017;45:D369-379.
39. Cunningham MT, Brandt JT, Laposata M, Olson JD. Laboratory diagnosis of dysfibrinogenemia. Arch Pathol Lab Med. 2002;126:499-505.
40. Besser MW, MacDonald SG. Acquired hypofibrinogenemia: current perspectives. J Blood Med. 2016;7:217-25.
41. Farrell DH. Pathophysiologic roles of the fibrinogen gamma chain. Curr Opin Hematol. 2004;11:151-5.
42. Fibrinogen on the brain: autoimmunity in demyelination diseases. 2015. https://www.jax.org/news-and-insights/2015/october/fibrinogen-on-the-brain-autoimmunity-in-demyelination-diseases. Accessed 18 Dec 2016.
43. Ryu JK, Petersen MA, Murray SG, Baeten KM, Meyer-Franke A, Chan JP, et al. Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation. Nat Commun. 2015;6:8164.
44. Henschen-Edman AH. Fibrinogen non-inherited heterogeneity and its relationship to function in health and disease. Ann N Y Acad Sci. 2001;936:580-93.
45. Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart J-C. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 1998;98:2088-93.
46. Falkner B, Sherif K, Sumner A, Kushner H. Hyperinsulinism and sex hormones in young adult African Americans. Metabolism. 1999;48:107-12.
47. Goldsztajn P, Hartwich J, Kwasniak M, Wenhrynowicz O, Zdzienicka A, Wybrańska I, et al. Decrease in the level of free cholesterol fraction HDL as a risk factor for threatened atherosclerosis in idiopathic hyperinsulinemia. Kardiol Pol. 1993;39:462-9. discussion 470-1.
48. Eichenbaum-Voline S, Olivier M, Jones EL, Naoumova RP, Jones B, Gau B, et al. Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol. 2004;24:167-74.
49. Sijbrands EJ, Hoffer MJ, Meinders AE, Havekes LM, Frants RR, Smelt AH, et al. Severe hyperlipidemia in apolipoprotein E2 homozygotes due to a combined effect of hyperinsulinemia and an SstI polymorphism. Arterioscler Thromb Vasc Biol. 1999;19:2722-9.
50. Fizelova M, Miilunpohja M, Kangas AJ, Soininen P, Kuusisto J, Ala-Korpela M, et al. Associations of multiple lipoprotein and apolipoprotein measures with worsening of glycemia and incident type 2 diabetes in 6607 non-diabetic Finnish men. Atherosclerosis. 2015;240:272-7.
51. Samson SL-A, Wong NCW. Role of Sp1 in insulin regulation of gene expression. J Mol Endocrinol. 2002;29:265-79.
52. Solomon SS, Majumdar G, Martinez-Hernandez A, Raghow R. A critical role of Sp1 transcription factor in regulating gene expression in response to insulin and other hormones. Life Sci. 2008;83:305-12.
53. Egea M, Metón I, Baanante IV. Sp1 and Sp3 regulate glucokinase gene transcription in the liver of gilthead sea bream (Sparus aurata). J Mol Endocrinol. 2007;38:481-92.
54. Mercader J, Ribot J, Murano I, Feddersen S, Cinti S, Madsen L, et al. Haploinsufficiency of the retinoblastoma protein gene reduces diet-induced obesity, insulin resistance, and hepatosteatosis in mice. Am J Physiol Endocrinol Metab. 2009;297:E184-193.